Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 214679
Company: AZURITY
Company: AZURITY
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| EPRONTIA | TOPIRAMATE | 25MG/ML | SOLUTION;ORAL | Prescription | AB | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 11/05/2021 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214679s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214679Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/214679Orig1s000TOC.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 03/06/2026 | SUPPL-12 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/214679s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/214679Orig1s012ltr.pdf | |
| 03/12/2025 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214679s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214679Orig1s009ltr.pdf | |
| 05/17/2024 | SUPPL-7 | Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214679s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/214679Orig1s007ltr.pdf | |
| 10/26/2022 | SUPPL-2 | Labeling-Container/Carton Labels, Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214679s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214679Orig1s002ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 03/06/2026 | SUPPL-12 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/214679s012lbl.pdf | |
| 03/06/2026 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/214679s012lbl.pdf | |
| 03/12/2025 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214679s009lbl.pdf | |
| 05/17/2024 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214679s007lbl.pdf | |
| 05/17/2024 | SUPPL-7 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214679s007lbl.pdf | |
| 10/26/2022 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214679s002lbl.pdf | |
| 10/26/2022 | SUPPL-2 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214679s002lbl.pdf | |
| 10/26/2022 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214679s002lbl.pdf | |
| 11/05/2021 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214679s000lbl.pdf |
EPRONTIA
SOLUTION;ORAL; 25MG/ML
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| EPRONTIA | TOPIRAMATE | 25MG/ML | SOLUTION;ORAL | Prescription | Yes | AB | 214679 | AZURITY |
| TOPIRAMATE | TOPIRAMATE | 25MG/ML | SOLUTION;ORAL | Prescription | No | AB | 217795 | ALKEM LABS LTD |